Ryan Specialty Group (RYAN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
3 Aug, 2026Business overview and market position
Operates as a leading specialty insurance firm, ranking #2 in wholesale brokerage and #1 in delegated underwriting authority by 2025 premium volume.
Connects over 35,000 retail brokers to specialized capacity providers and manages $32bn in premiums placed.
Maintains a broad client base with 350+ carrier trading partners and high producer/underwriter retention rates.
Offers a balanced revenue mix: 52% wholesale distribution and 48% delegated underwriting authority.
Expanded into reinsurance, alternative capital, and benefits, diversifying revenue streams.
Growth, innovation, and differentiation
Achieved 26% revenue CAGR and 31% adjusted EBITDAC CAGR from 2019–2025, with 93% total shareholder return since IPO.
Differentiation driven by scale, proprietary data, innovation, and a disciplined capital allocation framework.
Focuses on product innovation, expanding total addressable market in both wholesale and delegated authority segments.
Attracts and retains top talent, with 97% producer and 96% underwriter retention and a robust development program.
M&A strategy compounds growth, with 63 deals since founding and $530M in acquired revenue.
Financial performance and capital management
Revenue reached $3.2bn and adjusted EBITDAC $1.0bn in 2025, with strong organic growth and margins.
Maintains sufficient liquidity, $1.0bn RCF capacity, and a leverage corridor of 3–4x on a credit basis.
Increased quarterly dividend by 8% in 2026 and expanded share repurchase authorization to $600M.
Asset-light model supports strong free cash flow and disciplined capital allocation, prioritizing growth investments.
Holds stable credit ratings (Moody's Ba3, S&P BB-, Fitch BB+).
Latest events from Ryan Specialty Group
- Q2 2026 revenue up 7.2% to $916.6M; strong organic growth, but net income declined 13.1%.RYAN
Q2 2026 - Scale, innovation, and disciplined growth drive resilience and leadership in specialty insurance.RYAN
46th Annual William Blair Growth Stock Conference - Revenue up 15.2% to $795.2M, organic growth 11.8%, net income $40.6M, margin pressure ahead.RYAN
Q1 2026 - Record revenue, expanded shareholder rights, and a focus on performance-based leadership mark 2025.RYAN
Proxy Filing - Shareholders will vote on director elections, auditor ratification, and executive pay approval.RYAN
Proxy Filing - 2025 revenue up 21.3% to $3.1B, with 10.1% organic growth and $300M buyback authorized.RYAN
Q4 2025 - Revenue up 18.8% and net income up 40.8%, with margin and guidance both raised.RYAN
Q2 2024 - Q3 revenue up 20.5%, net income up 82.4%, and adjusted EBITDAC up 29.4% year-over-year.RYAN
Q3 2024 - Revenue up 25% and adjusted EBITDAC up 27.5%, but net income impacted by non-cash tax expense.RYAN
Q1 2025